Issued Patents All Time
Showing 1–22 of 22 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12378198 | Crystalline l-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in SIPI receptor-associated disorders | Anthony C. Blackburn, Ryan O. Castro, Mark Allen Hadd, You-An Ma, Antonio Garrido Montalban +3 more | 2025-08-05 |
| 11884626 | Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1P1 receptor-associated disorders | Anthony C. Blackburn, Ryan O. Castro, Mark Allen Hadd, You-An Ma, Antonio Garrido Montalban +3 more | 2024-01-30 |
| 11840515 | Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form c | Sagun Tandel, Roger Olsson, Mikael Hillgren, Matthew J. Fleming, Andreas Boudier +1 more | 2023-12-12 |
| 11827600 | Crystalline forms of trofinetide | Matthew Peterson, Martin Bernard Catherine Bousmanne, Cecilia Betti, David Jonaitis, Lisa M. McCracken +1 more | 2023-11-28 |
| 11091435 | Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in S1P1 receptor-associated disorders | Anthony C. Blackburn, Ryan O. Castro, Mark Allen Hadd, You-An Ma, Antonio Garrido Montalban +3 more | 2021-08-17 |
| 10981871 | Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form C | Sagun Tandel, Roger Olsson, Mikael Hillgren, Matthew J. Fleming, Andreas Boudier +1 more | 2021-04-20 |
| 10981870 | Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form | Sagun Tandel, Roger Olsson, Mikael Hillgren, Matthew J. Fleming, Andreas Boudier +1 more | 2021-04-20 |
| 10676435 | Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound 1) for use in SIPI receptor-associated disorders | Anthony C. Blackburn, Ryan O. Castro, Mark Allen Hadd, You-An Ma, Antonio Garrido Montalban +3 more | 2020-06-09 |
| 10597363 | Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form C | Sagun Tandel, Roger Olsson, Mikael Hillgren, Matthew J. Fleming, Andreas Boudier +1 more | 2020-03-24 |
| 10583122 | Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related thereto | Lee Alani Selvey, Paul Maffuid, Yun Shan, William L. Betts, III, Deam Windate Given, III +2 more | 2020-03-10 |
| 10543193 | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto | Weitong Dong, Mark Macias, Suzanne Michiko Sato, Lee Alani Selvey | 2020-01-28 |
| 10301262 | Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disorders | Anthony C. Blackburn, Ryan O. Castro, Mark Allen Hadd, You-An Ma, Antonio Garrido Montalban +3 more | 2019-05-28 |
| 10117851 | Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related thereto | Lee Alani Selvey, Paul Maffuid, Yun Shan, William L. Betts, III, Deam Windate Given, III +2 more | 2018-11-06 |
| 10071075 | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto | Weitong Dong, Mark Macias, Suzanne Michiko Sato, Lee Alani Selvey | 2018-09-11 |
| 9801856 | Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related thereto | Lee Alani Selvey, Paul Maffuid, Yun Shan, William L. Betts, III, Deam Windate Given, III +2 more | 2017-10-31 |
| 9745270 | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto | Weitong Dong, Mark Macias, Suzanne Michiko Sato, Lee Alani Selvey | 2017-08-29 |
| 9353064 | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto | Weitong Dong, Mark Macias, Suzanne Michiko Sato, Lee Alani Selvey | 2016-05-31 |
| 9126946 | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto | Weitong Dong, Mark Macias, Suzanne Michiko Sato, Lee Alani Selvey | 2015-09-08 |
| 9034911 | Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related thereto | Lee Alani Selvey, Paul Maffuid, Yun Shan, William L. Betts, III, Deam Windate Given, III +2 more | 2015-05-19 |
| 8822727 | Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine | Ryan O. Castro, Tawfik Gharbaoui, Xiao-Xiong Lu, You-An Ma, Nicholas D. San Martin | 2014-09-02 |
| 8299241 | Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof | Tawfik Gharbaoui, Sagun Tandel, You-An Ma, John R. Fritch | 2012-10-30 |
| 7425630 | Processes for preparing pyrazolo[3,4-d]pyrimidine ethers | Tawfik Gharbaoui, Dipanjan Sengupta, Edward A. Lally, Naomi S. Kato, Natalie Rodriguez | 2008-09-16 |